Acquisition set to take ocular therapies to patients
Gyroscope Therapeutics Holdings, a portfolio company of life sciences investment trust Syncona Ltd, has been acquired by Novartis for up to $1. Click to read more...
Stay updated with breaking news from Syncona Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gyroscope Therapeutics Holdings, a portfolio company of life sciences investment trust Syncona Ltd, has been acquired by Novartis for up to $1. Click to read more...
UK's FTSE 100 inched lower on Wednesday on mounting concerns over the impact of the Omicron coronavirus variant on economic recovery and weaker-than-expected quarterly growth data. The... | December 22, 2021
Novartis buys UK gene therapy firm Gyroscope for up to USD1.5 billion | Financial News
Swiss drugmaker Novartis AG is buying Gyroscope Therapeutics for up to $1.5 billion, looking to bolster its gene therapy roster with the British firm's treatment for geographic atrophy, a leading...
Omicron Weighs on Already Struggling UK Economy 1002 GMT - Economic growth slowed and the U.K.'s current account deficit widened in the third quarter, showing that the economy was struggling to...